Free Republic

The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. In a recent preprint case report, Veterans Affairs researchers reported that a 71-year-old male who took the pill, also known as nirmatrelvir, experienced a “rapid and progressive reduction” in the viral load of SARS-CoV-2, the virus that causes COVID-19. But four days after completing the treatment course, there was a “surprising...

An alarming admission was found near the bottom of a recent New York Times article about pharmaceutical giant Merck’s new Covid drug molnupiravir. Approved by the FDA two weeks ago, the drug was studied on isolated hamster cells for 32 days before being given the green light. While the FDA narrowly voted to recommend emergency use authorization for the drug, France’s National Authority of Health on Friday cited the pill’s own lack of efficacy as it ruled it will not be used in the European nation. According to the NYT report, “A team of researchers at the University of North...

The New York City clinic where Joan Rivers suffered a fatal complication during a medical procedure is losing its accreditation at the end of the month, a federal agency said Monday. “Yorkville Endoscopy no longer meets the conditions for a supplier of ambulatory surgical center services,” the Centers for Medicare Services said in a statement. As of Jan. 31, the Manhattan medical facility will no longer be eligible to receive federal funds for services provided to Medicare and Medicaid beneficiaries. …